Myofibrillar myopathy type 6 (MFM6) is a rare genetic muscle disorder that leads to severe muscle weakness and a drastically ...
Johns Hopkins researchers have developed a powerful new AI tool called Splam that can identify where splicing occurs in genes—an advance that could help scientists analyze genetic data with greater ...
A novel strategy that combines computational and experimental approaches has allowed researchers at Baylor College of ...
Researchers from the Keck School of Medicine of USC have made an important advance toward understanding-and potentially treating-a rare cardiomyopathy (heart muscle disease) that is present from birth ...
The FDA has granted an accelerated approval for Otarmeni (lunsotogene parvec-cwha), the first gene therapy to treat patients ...
Randomized trials of platelet function and genetic testing to guide antiplatelet decisions following PCI have produced notoriously mixed results: now, an updated consensus document aims to fill some ...
Scientists studying animals at high altitudes discovered a previously unknown mechanism that is key for regulating myelin ...
Morning Overview on MSN
FDA approves Regeneron’s first gene therapy for inherited deafness in children
When the parents of a toddler born profoundly deaf learned their child carried mutations in both copies of the OTOF gene, a ...
In the double helix structure of DNA, thymine forms a base pair with adenine through two hydrogen bonds. This specific pairing is known as complementary base pairing and is essential for the stability ...
Please provide your email address to receive an email when new articles are posted on . Researchers evaluated adults without a history of physician-diagnosed COPD. Area under the curve went up with ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results